← Back to headlines
Lilly's Once-Monthly Eczema Injectable Shows Durable Disease Control
Eli Lilly announced that its once-monthly injectable treatment for eczema delivered durable disease control in clinical trials, offering a potential new option for patients.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Manila Water Foundation Promotes Oral Health and Hygiene in Communities
just now
Assisted Suicide of 25-Year-Old Rape Victim in Spain Sparks Outcry
17m ago
Hospital Body Swap in Sweden Leads to Son Attending Mother's Funeral by Mistake
17m ago
B.C. Woman Offered MAID Before Other Treatments, Declines and Climbs Volcano
23m ago